Story Navigation
-
Chronic IllnessNovartis Institutes for BioMedical ResearchScientific ResearchBreaking a vicious cycle of inflammation
Novartis researchers aim to quash inflammation to treat chronic disease.
-
DiscoveryCOVID-19Local ImpactWorking at NovartisClinical TrialsDrug DevelopmentHelping clinical trial patients during a lockdown
Yan Zhao talks about how her team in China responded to an emerging public health crisis.
Discovery -
Access to HealthcareAccess to HealthcareCancerCOVID-19OncologyWorking at NovartisClinical ResearchCancer didn’t stop for COVID-19
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Access to Healthcare -
Access to HealthcareCOVID-19Infectious DiseasesInnovationWorking at NovartisStreamlining systems to respond to COVID-19
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Access to Healthcare -
DiscoveryCOVID-19Disease EradicationInfectious DiseasesWorking at NovartisClinical ResearchClinical TrialsMoving from speculation to science during a pandemic
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
Discovery -
DiscoveryCOVID-19Disease EradicationInfectious DiseasesWorking at NovartisScientific ResearchIt takes an R&D village to fight a pandemic
Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Discovery -
From Our LabsCOVID-19Disease EradicationInnovationScientific ResearchA visual tour of scientific strategies for combating coronavirus
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
From Our Labs -
People and CultureCOVID-19DigitalClinical ResearchClinical TrialsClinical ScienceDrug DevelopmentGoing the extra mile to keep clinical trials on track during the COVID-19 pandemic
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
People and Culture -
DiscoveryBiomedical ResearchCOVID-19Data ScienceDiseasesInfectious DiseasesClinical TrialsBiomedical ScienceCOVID-19: Answering your top questions
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Discovery -
DiscoveryDrug DesignInnovationNovartis Institutes for BioMedical ResearchScientific ResearchVisualizing molecular glues
Molecular glues are a new type of medicine inspired by nature’s matchmakers.
Discovery -
Patient PerspectivesDisease AwarenessDiseasesHeart FailurePatient VoicesDrug DevelopmentCaring for someone with heart failure
Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.
Patient Perspectives -
Data ScienceDigitalEmerging TechnologyFuture of HealthcareInnovationThe data42 program shows Novartis’ intent to go big on data and digital
Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.
Pagination
- ‹ Previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 30
- › Next page